APA (7th ed.) Citation

IH, L., SJ, L., J, K., YH, L., GO, C., JM, K., . . . YS, C. (2024). Exploring the effect of BRCA1/2 status on chemotherapy-induced hematologic toxicity in patients with ovarian cancer. Cancer chemotherapy and pharmacology, 94(1), 103. https://doi.org/10.1007/s00280-024-04670-8

Chicago Style (17th ed.) Citation

IH, Lee, et al. "Exploring the Effect of BRCA1/2 Status on Chemotherapy-induced Hematologic Toxicity in Patients with Ovarian Cancer." Cancer Chemotherapy and Pharmacology 94, no. 1 (2024): 103. https://doi.org/10.1007/s00280-024-04670-8.

MLA (9th ed.) Citation

IH, Lee, et al. "Exploring the Effect of BRCA1/2 Status on Chemotherapy-induced Hematologic Toxicity in Patients with Ovarian Cancer." Cancer Chemotherapy and Pharmacology, vol. 94, no. 1, 2024, p. 103, https://doi.org/10.1007/s00280-024-04670-8.